bone marrow can develop into leukemia, which is clonal cancer. Acute Myeloid Leukemia (AML) developed as a result of somatic mutations in the precursor cells of the myeloid lineage along
Acute myeloid leukemia (AML) patients with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene can be treated with tyrosine kinase inhibitors (TKIs) targeting FLT3. However, many patients develop ... hypothesized…
Objectives: Acute myeloid leukemia (AML) exhibits one of the therapeutic challenges to the clinicians. Despite the increasing knowledge about its underlying pathophysiology, there is little contribution of this massive…
study is to evaluate the correlation between HSIL on cytology and histological CIN2+ in AML, Antwerp and to compare two liquid-based cytological techniques ThinPrep® LBC (TP) and SurePath ... another 120 from 2010…
unmet need for new effective and less toxic therapies for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients. This is particularly important for the elderly patients who are often ... number of…
methods were developed for the simultaneous determination of the antihypertensive drugs candesartan (CAN), Amlodipine (AML) and hydrochlorothiazide (HCT) in their combined tablet dosage form. Method I: capillary zone…
Acute myeloid leukemia (AML) is a heterogeneous disease which its identification owes to the discovery of genetic and epigenetic disorders. Micro-RNAs (miRs) are small, non-coding RNAs that have ... impact and…
Acute myelogenous leukemia (AML) is a clinically most devastating disease with dismal prognosis and survival rate. Efforts to identify new therapeutic targets to overcome myeloid differentiation blockade were largely…
immunophenotyping analysis were performed. This study showed distribution of immunophenotyping characters between studied AML and ALL cases. Results: The most abundant immunophenotyping features in acute myeloid…
sequenced from the cancer cell and the normal cell for 50 Acute Myeloid Leukemia (AML) patients. Among mutations, duplicated-indels, which are frequently found at the cancer cell
Background: Acute Myeloid Leukemia (AML) is a malignant condition that affects the bone marrow's myeloid cell lineage. Genetic abnormalities result in an accumulation of myeloblasts ... peripheral blood. This study…
workers reported the expression of nucleophosmin (NPM) gene mutation in acute myeloblastic leukemia (AML), and various research in succession clarified the role of mNPM in AML. We previously studied ... proliferative…
diagnosed with Acute Myeloid Leukemia (AML), with t(8,21), April 2015, when he presented with constitutional symptoms and cytopenias. He was managed with 3+7 induction chemotherapy followed ... FLAG-M chemotherapy…
small portion of patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but the mechanisms underlying the efficacy of different epigenetic therapies are unknown. In this study, we performed
gene-specific approaches, have revealed that aberrant promoter methylation is a common event in AML. One such gene, CCAAT/enhancer binding protein α (C/EBP α), is a key transcription ... promoter methylation of the CEBP…
Acute myeloid leukemia (AML) is a heterogeneous group of disorder. Recurrent translocations t (15; 17), t (8; 21) and inv (16) have good prognosis and are recognized as a biomarker ... prognostication in AML, whereas…
treated with prednisolone. In 1997, she was diagnosed with acute megakaryoblastic leukemia (AML-M7), for which she received chemotherapy and achieved partial remission. She received supportive therapy, including blood…
occurrence, development and prognosis of leukemia, but its relationship with Acute Myeloid Leukemia (AML) is not clear. This study aims to explore the relationship between AFFs and the prognosis ... AML through…
Cutaneous manifestations are commonly observed in the clinical course of Acute Myelogenous Leukemia (AML). In 10% to 15% of cases, skin eruptions arise from leukemic skin infiltration and are known
autophagy and its relationship with therapeutic outcomes in patients with acute myelocyctic leukemia (AML). Here we report the differential gene expression pattern of some autophagy-related genes (ATGs) that have…
Tyrosin kinase inhibitor antitumor bioactive was studied. The ascetic form of myelogenous leukemia AML-193 (transplantation dose 1x105 tumor cells/mouse, i. p.), in hybrid mice BDF1, was used
bone marrow morphology, 27% patients had ALL-L1, 38% had ALL-L2, 05% had AML-M1, 21% had AML-M2, 06% had AML-M3, 02% had AML ... AML-M5. Immunophenotyping by flow cytometry confirms 50% patients to be B-ALL, 07% to be…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.